Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 261

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT

Psychedelic Alpha Crossword: Summer 2026

Weekly Psychedelic Policy Briefing – August 2, 2026

Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Without Psychedelics

Psilocybin Trial in Veterans With Treatment-Resistant PTSD Reports 75% Remission at One Month

Red Light Holland to Partner with Leading Fresh and Dried Mushroom...

PT249 – Hadas Alterman, Serena Wu, and Adriana Kertzer of Plant...

Filament Announces Shareholder Approval of Amalgamation and Closing of Private Placement...

Psychedelics and Perception Part 1: The First Era of Research

Red Light Holland Provides Initial FAQ in connection with Transaction with...

Psychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications;...

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

PTSF64 – The First Woman to Take Acid, The Drug Policy...

atai Life Sciences Announces Pricing of Upsized Initial Public Offering

Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial

Load more

EDITOR PICKS

From Sonora to Big Pharma: Kimon de Greef Traces the Strange...

Psychedelic Alpha Crossword: Summer 2026

Psilocybin Trial in Veterans With Treatment-Resistant PTSD Reports 75% Remission at...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©